bioRxivPathologyPreprint
Neuronal SNCA transcription during Lewy body formation
T. Kon, S. L. Forrest, S. Lee, I. Martinez Valbuena, J. Li, N. Nassir, M. J. Uddin, A. E. Lang, G. G. Kovacs
Abstract
BackgroundMisfolded -synuclein (-syn) is believed to contribute to neurodegeneration in Lewy body disease (LBD) based on considerable evidence including a gene-dosage effect observed in relation to point mutations and multiplication of SNCA in familial Parkinsons disease. A contradictory concept proposes early loss of the physiological -syn as the major driver of neurodegeneration. There is a paucity of data on SNCA transcripts in various -syn immunoreactive cytopathologies. MethodsSNCA transcripts in neurons without and with various -syn immunoreactive cytopathologies in the substantia nigra and amygdala in LBD (n = 5) were evaluated using RNAscope combined with immunofluorescence for disease-associated -syn. Single-nucleus RNA sequencing was performed to elucidate cell-type specific SNCA expression in non-diseased frontal cortex (n = 3). ResultsSNCA transcripts in neurons with punctate -syn immunoreactivity were preserved both in the substantia nigra and amygdala but were reduced in neurons with compact -syn inclusions. Only single SNCA transcripts were detected in astrocytes with or without -syn immunoreactivity in the amygdala. Single-nucleus RNA sequencing revealed that excitatory and inhibitory neurons, oligodendrocyte progenitor cells, oligodendrocytes, and homeostatic microglia expressed SNCA transcripts, while expression was largely absent in astrocytes and microglia. ConclusionsThe preserved cellular SNCA expression in the more abundant non-Lewy body type -syn cytopathologies provides a pool for local protein production that can aggregate and serve as a seed for misfolded -syn. Successful segregation of disease-associated -syn is associated with the exhaustion of SNCA production in the terminal cytopathology, the Lewy body. Our observations support a therapeutic strategy incorporating a finely tuned dual approach targeting the elimination of misfolded -syn along with the reduction of the SNCA transcription to avoid feeding of pathological -syn seeding.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single cell transcriptomics reveals enrichment of aggregation-prone alpha-synuclein isoforms across synucleinopathies
Elliot Keats Shwab, Webb Pierson, … Ornit Chiba‐Falek·bioRxiv·Oct 13, 2025
- SENP2-based N-terminal truncation of α-synuclein in Lewy pathology propagation
Katsutoshi Taguchi, Yoshihisa Watanabe, Masaki Tanaka·iSciencePeer-reviewed·Jan 31, 2025
- Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders
Melek Firat Altay, Alan King Lun Liu, … Hilal Ahmed Lashuel·Acta Neuropathologica CommunicationsPeer-reviewed·Nov 12, 2022
- The process of Lewy body formation, rather than simply alpha-synuclein fibrillization, is the major driver of neurodegeneration in synucleinopathies
Anne‐Laure Mahul‐Mellier, Johannes Burtscher, … Hilal Ahmed Lashuel·Proceedings of the National Academy of SciencesPeer-reviewed·Feb 19, 2020
- Lewy-MSA hybrid fold drives distinct neuronal a-synuclein pathology
Masahiro Enomoto, Iván Martínez-Valbuena, … Gábor Géza Kovács·Communications BiologyPeer-reviewed·Jun 16, 2025
- α-Synuclein aggregates in corticostriatal terminals impair glutamatergic transmission in the absence of neurodegeneration
Charlotte F. Brzozowski, Zoe N. Fokakis, … Laura A. Volpicelli‐Daley·bioRxiv·Aug 7, 2026